Insider · CIK 0001883325
Miller Steven Clive
cfoofficer
Files at WRBY (Warby Parker Inc.). First filing Dec 5, 2024, latest Dec 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $503k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 28Weak | sell 310b5-1 | WRBY Warby Parker Inc. | $167k | 7,016 | -4% | - | |
| 37Weak | sell 3 | WRBY Warby Parker Inc. | $336k | 14,853 | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | WRBY Warby Parker Inc. | SOpen-market sale Class A Common Stock10b5-1 | -7,016 | $23.85 | $167k | 182,130 | Dec 13, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | MOption exercise Class A Common Stock | +26,511 | $0.00 | $0 | 203,999 | Dec 5, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | SOpen-market sale Class A Common Stock | -14,853 | $22.61 | $336k | 189,146 | Dec 5, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | MOption exercise Restricted Stock Unitsderivative | -1,981 | $0.00 | $0 | 1,321 | Dec 5, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | MOption exercise Restricted Stock Unitsderivative | -5,096 | $0.00 | $0 | 13,589 | Dec 5, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | MOption exercise Restricted Stock Unitsderivative | -8,879 | $0.00 | $0 | 76,958 | Dec 5, 2024 |
| Dec 3, 2024 | WRBY Warby Parker Inc. | MOption exercise Restricted Stock Unitsderivative | -10,555 | $0.00 | $0 | 133,689 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.